Hungarian drug maker Gedeon Richter has made a $604 million takeover bid for Mayne Pharma just a week after Mayne announced plans to sell its Adelaide manufacturing plant.
Gedeon Richter’s offer of $6.40 a share in cash is almost double Mayne’s closing price on Monday of $3.21, representing a significant windfall for shareholders, although it is well below the $7.40 a share that US healthcare giant Cosette was willing to pay in 2025.
Gift articles to anyone you choose each month when you subscribe.